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Abstract: 
Background: Primary hyperparathyroidism with pancreatitis is very rare during pregnancy. The pregnant 
state presents a challenge to the diagnosis of hypercalcemia related to the many physiological changes that 
occur. 
Objective: To report a case of primary hyperparathyroidism in a pregnant patient, and to advocate a 
successful management with satisfactory outcome. 
Results: A 36-year-old multigravida Saudi woman presented during her 34th week of gestation with a five 
days history of epigastric pain, nausea and vomiting.Diagnosis was made as Primary hyperparathyroidism 
with severe hypercalcemia in pregnancy complicated by acute pancreatitis. 
She was initially managed with conservative medical measures and due to the failure of medical 
management, a multidisplinary team decided to terminate the pregnancy by cesarean section and to do 
parathyroidectomy at the same time at 34-weeks gestation. The maternal and fetal outcome was quite 
satisfactory. To the best of our knowledge, this is one of the rare case report in the literature with such 
finding and satisfactory outcome. 
Conclusions: Early diagnosis and appropriate management of Primary Hyperparathyrodisim (PHP) during 
pregnancy is important for better outcome. Multidisciplinary management decisions can significantly 
reduce the morbidity and mortality associated with the disease during pregnancy. 
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Introduction: 
Primary hyperparathyroidism (PHP) is the third most common endocrine disorder after diabetes 
and thyroid disease, and women are affected twice as often as men (1,2). Most patients suffering 
from PHP are older than 45 years, but 25% are diagnosed in their childbearing years. 
PHP has been reported to lead to maternal complications in 2/3 of cases (3). The presentation of 
hypercalcemia in pregnancy related to PHP is variable and ranges from asymptomatic in 23% to 
symptoms such as nausea, vomiting, and anorexia in 36%, weakness and fatigue in 34%, and 
neurological/psychiatric manifestations in 26% based on a review of 70 women with PHP during 
pregnancy (4). Other reports suggest that up to 80% of patient with hyperparathyroidism may be 
asymptomatic (5,4). 
Acute pancreatitis is reported to be a serious but rare presentation of PHP in pregnancy. (6,7,8,) 
However, recent population-based studies have refuted this association. (9)  
The preference for surgery over medical management (with oral phosphates, calcitonin, calcium 
wasting diuretics, etc) has been well established. (10) 
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Because of the significant maternal, fetal and neonatal risks outlined, and the improved safety of 
general anaesthetic during pregnancy, surgical management is increasingly recommended. (11) It is 
thought that the risks are outweighed by the benefits to reduce maternal serum calcium back to 
normal range. It is supported by research indicating that neonatal complication rates are 37% after 
medical treatment and only 10% after surgical intervention. (12) 
 
Case Report: 
A 36-year-old multigravida (G8P4A3) with a live and well children Saudi woman presented during 
her 34th week of gestation with a five days history of epigastric pain, nausea and vomiting.The 
abdominal pain was epigastric, dull in nature radiated to the back, exacerbated by eating and 
progressively increases over last 5 days. 
The vomiting was severe and not projectile whatever she took orally, but not reported neither 
heamatemesis, change in bowel habit, history of fever and jaundice nor change in stool or urine 
color. 
Her pregnancy was unremarkable up til this time. She denied any history of bone pain or fracture, 
renalstone, hematuria, joint pain, muscle pain or weight change, dysuria, constipation, polydipsia, 
polyuria, weight loss, anorexia, or muscle weakness during her pregnancy. She had no history of 
calcium disorders, kidney stones, fractures, osteoporosis or endocrinopathies. Also no history of 
cold intolerance or hotness, palpitation or shortness of breath, postural dizziness, headache or 
visual problems, skin eruption or hyperpigmentation. There were no reported history of lower 
abdominal pain, per vaginal bleeding and fetal movement was good. 
Family history was negative for calcium disorders, kidney stones, fractures, osteoporosis, 
endocrinopathies or parathyroid disorders, but her father had esophageal cancer and her 
grandmother had a history of thyroid cancer.   
She was taking folic acid and multivitamins. She was not taking thiazide diuretics, antacids, or 
lithium which could influence her calcium status. She was a housewife and all her children all are 
well. 
The patient was unbooked in our hospital, and was followed in a private hospital and for the first 
time presented to our hospital in this pregnancy with this complain. Regarding her past medical 
history there was no history of diabetes mellitus, hypertension or any other chronic or endocrine 
disease. 
On physical examination, she was conscious, oriented, in pain and distress and looked moderately 
sick. Her blood pressure was 114/56 mmHg, heart rate 85-110/min and regular, respiratory rate 
18/minute, and temp 36.7ºC and oxygen saturation 98 %. 
There were no palpable neck masses, jaw abnormalities, cervical or supraclavicular 
lymphadenopathy. 
On abdominal examination, there was mild epigastric tenderness and the uterus was 34weeks 
consistent with her gestational age. She had no kyphosis or bone tenderness. There was significant 
proximal myopathy with no bony tenderness. The remainder of the systemic examination was 
unremarkable. 
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The following differential diagnoses were considered acute gastroenteritis, peptic ulcer disease, 
acute cholecystitis, acute pancreatitis, gestational diabetes with diabetic keto acidosis, inferior 
myocardial infarction and abruptio placentae. 
Initial laboratory evaluation revealed severe hypercalcemia with a calcium level 16.3 mg/dL 
(reference range 8.5–10.3), albumin 37g/L (3.2–5.5), and a phosphorous level 0.61mg/dL (2.4–
4.1). She had normal renal function, her 25 hydroxy vitamin D was 19.1 nmol/L (8.9–46.7). 
On further workup, she was found to have an elevated PTH level of 697pg/mL (16–48pg/mL) and 
serum amylase was 932 U/L (normal range: 28-100 U/L).Complete blood count and liver function 
tests were normal. She was biochemically euthyroid. Lipid profile was within normal ranges. 
U/S abdomen showed diffusely hypoechoic pancrease suggestive of pancreatitis, bilateral renal 
medullary nephrocalcinosis and there were no gall stones and normal common bile duct (CBD). 
Ultrasonography of her neck revealed a two well defined hypoechoic nodules noted on the 
posterior aspect of left lobe highly suggestive of parathyroid adenoma (Figure 1). 
An obstetrical ultrasound confirmed alife single intrauterine gestation consistent with 34 week of 
gestation. 
Based upon her previously mentioned history and investigations a diagnosis of Primary 
hyperparathyroidism with severe hypercalcemia in pregnancy complicated by acute pancreatitis 
was made. 
She was initially managed with conservative measures namely: eucalcemic diet and aggressive 
hydration with minimal improvement in her clinical or biochemical status. Due to her persistent 
symptomatic hypercalcemia despite conservative measures a multidisciplinary team was involved 
including an endocrine surgeon, an obstetrician, an endocrinologist, a neonatologist and an 
anestheologist for their opinion for further management. They decided to terminate the pregnancy 
by cesarean section and to do parathyroidectomy at the same time at 34-week gestation. Outcome 
was Baby girl, fetal weight 2090 g, Apgar score 7 and 8, admitted to neonatal intensive care unit 
(NICU) with respiratory distress syndrome and had CPAP for 5 days and neonatal jaundice  for 
which she had phototherapy for 1 day and hypercalcemia 1 reading and hypomagnesemia 1 
reading. 
There was a marked drop in the intraoperative PTH levels after the removal of the enlarged 
parathyroid gland, confirming a successful operation. Pathological evaluation of the resected mass 
demonstrated an enlarged parathyroid gland. Histopathologic examination of the parathyroid gland 
was consistent with a parathyroid adenoma (Figure 2). The patient was discharged home at 4 
postoperative daysin good condition with a normal calcium level (2,58 mmol/l) and a life baby. 
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Figure 1: 
Ultrasonography of her neck revealed a two well defined hypoechoic nodules noted on 
posterior aspect of left lobe highly suggestive of parathyroid adenoma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Enlarged 
parathyroid glandconsistent with a parathyroid adenoma 
 
Discusion: 
This case highlights the significance of timely recognition and effective management of PHP in 
pregnancy, leading to optimization of both maternal and fetal outcomes. 
Maternal complication rates related to PHP during pregnancy have been reported to be as high as 
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67% (3), and fetal complications are reported to occur in up to 80% cases (13). Early identification 
and management of this condition in pregnancy can significantly reduce fetal, neonatal, and 
maternal morbidity and mortality associated with this important condition. 
A diagnosis of such cases is difficult in pregnancy because the clinical picture confuses with 
pregnancy physiology. The work up done for this case has been appreciated; depending on clinical 
presentation and laboratory findings. A diagnosis of PHP in pregnancy should be considered with 
the simultaneous findings of an elevated total corrected calcium level (>9.5 mg/dL) or ionized 
calcium level, hypophosphatemia (<2.5 mg/dL), and an elevated serum PTH level in the absence 
of other causes of hypercalcemia (14). Additionally, the diagnosis should be considered in any 
patient who presents with the classic features of hyperparathyroidism such as pancreatitis, 
fractures, or peptic ulcer disease (PUD) (15). 
Ultrasonography for the neck and abdomen done for this case has played a major role to reach the 
diagnosis. Ultrasonography of the neck is the investigation of choice during pregnancy for 
localization of parathyroid adenomas with a sensitivity of 69% and a specificity of 94% (16). 
As the diagnosis was made in the 3rd trimester, a discussion with the patient was undertaken 
regarding the risks and benefits of surgery. Some authors advocating that surgery in the 3rd 
trimester is safe and reduces fetal complications from maternal PHP (17). In our setting we have 
enhanced preoperative localization, improved surgical procedures, and the ability to perform rapid 
intraoperative serial PTH levels. In such situations the operative time can be dramatically reduced 
(18,19). There is only one other prior case report published of the use of intraoperative PTH 
monitoring to confirm the successful surgical removal of an adenoma in a pregnant patient (20). 
Surgery was performed, although it is reported that surgery during the 3rd trimester it is associated 
with a higher risk of neonatal complications and mortality (21); however, it is acceptable when the 
benefit outweighs the risk (17,22). In this case because all efforts failed and urgent 
parathyroidectomy and cesarean section were done. The management plan adopted was 
satisfactory with appreciated maternal and fetal outcome. 
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